These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29044628)

  • 1. Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.
    Hirabayashi M; Asano Y; Yamashita T; Miura S; Nakamura K; Taniguchi T; Saigusa R; Takahashi T; Ichimura Y; Miyagawa T; Yoshizaki A; Miyagaki T; Sugaya M; Sato S
    J Dermatol; 2018 Feb; 45(2):182-188. PubMed ID: 29044628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
    Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
    Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors.
    Kawaguchi Y; Takagi K; Hara M; Fukasawa C; Sugiura T; Nishimagi E; Harigai M; Kamatani N
    Arthritis Rheum; 2004 Jan; 50(1):216-26. PubMed ID: 14730619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.
    Taniguchi T; Miyagawa T; Toyama S; Yamashita T; Nakamura K; Saigusa R; Ichimura Y; Takahashi T; Toyama T; Yoshizaki A; Sato S; Asano Y
    Exp Dermatol; 2018 Sep; 27(9):1030-1037. PubMed ID: 29947047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vanadium stimulates human bronchial epithelial cells to produce heparin-binding epidermal growth factor-like growth factor: a mitogen for lung fibroblasts.
    Zhang L; Rice AB; Adler K; Sannes P; Martin L; Gladwell W; Koo JS; Gray TE; Bonner JC
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):123-31. PubMed ID: 11159045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased serum levels and tissue expression of matrix metalloproteinase-12 in patients with systemic sclerosis: correlation with severity of skin and pulmonary fibrosis and vascular damage.
    Manetti M; Guiducci S; Romano E; Bellando-Randone S; Conforti ML; Ibba-Manneschi L; Matucci-Cerinic M
    Ann Rheum Dis; 2012 Jun; 71(6):1064-72. PubMed ID: 22258486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis.
    Kumánovics G; Görbe E; Minier T; Simon D; Berki T; Czirják L
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-138-44. PubMed ID: 24773853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum KL-6 levels in patients with systemic sclerosis: association with the severity of pulmonary fibrosis.
    Sato S; Nagaoka T; Hasegawa M; Nishijima C; Takehara K
    Dermatology; 2000; 200(3):196-201. PubMed ID: 10828626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth differentiation factor 15, a marker of lung involvement in systemic sclerosis, is involved in fibrosis development but is not indispensable for fibrosis development.
    Lambrecht S; Smith V; De Wilde K; Coudenys J; Decuman S; Deforce D; De Keyser F; Elewaut D
    Arthritis Rheumatol; 2014 Feb; 66(2):418-27. PubMed ID: 24504814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
    Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid- and Epithelial-derived Heparin-Binding Epidermal Growth Factor-like Growth Factor Promotes Pulmonary Fibrosis.
    Hult EM; Gurczynski SJ; O'Dwyer DN; Zemans RL; Rasky A; Wang Y; Murray S; Crawford HC; Moore BB
    Am J Respir Cell Mol Biol; 2022 Dec; 67(6):641-653. PubMed ID: 36036796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts.
    Liakouli V; Cipriani P; Di Benedetto P; Panzera N; Ruscitti P; Pantano I; Berardicurti O; Carubbi F; Esteves F; Mavria G; Del Galdo F; Giacomelli R
    Sci Rep; 2019 Mar; 9(1):4589. PubMed ID: 30872612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological inhibition of heparin-binding EGF-like growth factor promotes peritoneal angiogenesis in a peritoneal dialysis rat model.
    Li Z; Yan H; Yuan J; Cao L; Lin A; Dai H; Ni Z; Qian J; Fang W
    Clin Exp Nephrol; 2018 Apr; 22(2):257-265. PubMed ID: 28710535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin-binding epidermal growth factor-like growth factor and transforming growth factor-alpha in human non-small cell lung cancers.
    Chong IW; Lin SR; Lin MS; Huang MS; Tsai MS; Hwang JJ
    J Formos Med Assoc; 1997 Aug; 96(8):579-85. PubMed ID: 9290266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin-binding epidermal growth factor contributes to COPD disease severity by modulating airway fibrosis and pulmonary epithelial-mesenchymal transition.
    Lai T; Li Y; Chen M; Pan G; Wen X; Mai Z; Yuan Y; Lv Y; Lv Q; Cen R; Yi H; Wen M; Li D; Wu B; Wu D; Cao C
    Lab Invest; 2018 Sep; 98(9):1159-1169. PubMed ID: 29581578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-binding EGF-like growth factor accelerates keratinocyte migration and skin wound healing.
    Shirakata Y; Kimura R; Nanba D; Iwamoto R; Tokumaru S; Morimoto C; Yokota K; Nakamura M; Sayama K; Mekada E; Higashiyama S; Hashimoto K
    J Cell Sci; 2005 Jun; 118(Pt 11):2363-70. PubMed ID: 15923649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Localized expression of tenascin in systemic sclerosis-associated pulmonary fibrosis and its regulation by insulin-like growth factor binding protein 3.
    Brissett M; Veraldi KL; Pilewski JM; Medsger TA; Feghali-Bostwick CA
    Arthritis Rheum; 2012 Jan; 64(1):272-80. PubMed ID: 21898349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of aquaporin-3 and epidermal growth factor receptor expression and activation in systemic sclerosis dermal fibroblasts.
    Farhadi E; Mahmoudi M; Rahmani F; Yousefi B; Sarafnejad A; Kavosi H; Karimizadeh E; Jamshidi A; Gharibdoost F
    J Cell Physiol; 2019 Aug; 234(8):12876-12883. PubMed ID: 30536805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The transcription factor GLI2 as a downstream mediator of transforming growth factor-β-induced fibroblast activation in SSc.
    Liang R; Šumová B; Cordazzo C; Mallano T; Zhang Y; Wohlfahrt T; Dees C; Ramming A; Krasowska D; Michalska-Jakubus M; Distler O; Schett G; Šenolt L; Distler JH
    Ann Rheum Dis; 2017 Apr; 76(4):756-764. PubMed ID: 27793816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 2 innate lymphoid cell counts are increased in patients with systemic sclerosis and correlate with the extent of fibrosis.
    Wohlfahrt T; Usherenko S; Englbrecht M; Dees C; Weber S; Beyer C; Gelse K; Distler O; Schett G; Distler JH; Ramming A
    Ann Rheum Dis; 2016 Mar; 75(3):623-6. PubMed ID: 26338035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.